Skip to main content
Top
Published in: International Journal of Hematology 4/2014

01-04-2014 | Images in Hematology

Ethylenediaminetetraacetate-dependent pseudothrombocytopenia accompanied by morphological changes

Authors: Weiyi Xu, Baode Chen, Yu Chen

Published in: International Journal of Hematology | Issue 4/2014

Login to get access

Excerpt

A 65-year-old female patient was referred to our hospital for diabetes mellitus, diabetic nephropathy, pulmonary infection, and hypertension on November 6, 2012. Following admission, findings from laboratory tests were as follows: white blood cell count, 14.76 × 109/L; hemoglobin, 123 g/L; platelet count, 28 × 109/L; creatinine, 272 μmol/L; fasting glucose, 14.26 mmol/L; prothrombin time, 14.6 s; d-dimer, 4800 μg/L. Tests for antinuclear and antineutrophil cytoplasmic antibodies were negative, but were positive for platelet-associated IgG. Dipotassium EDTA, sodium citrate, and heparin sodium were selected as the anticoagulants for blood cell counts, to exclude the influence of EDTA salt. We performed whole-blood cell counts measured by a Sysmex XE-2100 complete blood count analyzer, followed by blood smears and staining with a Sysmex sp1000i automated hematology slide preparation unit. The platelet and white blood cell counts were 12 × 109 and 6.9 × 109/L for EDTA-2K anticoagulants, 242 × 109 and 4.3 × 109/L for sodium citrate anticoagulants, 250 × 109 and 4.6 × 109/L for heparin sodium anticoagulants, respectively. The blood smear results are shown in Figs. 1 and 2.
Literature
1.
go back to reference Recommendations of the International Council for Standardization in Haematology for Ethylenediaminetetraacetic acid anticoagulation of blood for blood cell counting and sizing. International Council for Standardization in Haematology: expert panel on cytometry. Am J Clin Pathol. 1993;100(4):371–372. Recommendations of the International Council for Standardization in Haematology for Ethylenediaminetetraacetic acid anticoagulation of blood for blood cell counting and sizing. International Council for Standardization in Haematology: expert panel on cytometry. Am J Clin Pathol. 1993;100(4):371–372.
2.
go back to reference Dabadie M, Valli N, Jacobin MJ, Laroche-Traineau J, Barat JL, Ducassou D, Nurden AT, Clofent-Sanchez G. Characterisation, cloning and sequencing of a conformation-dependent monoclonal antibody to the alphaIIbbeta3 integrin: interest for use in thrombus detection. Platelets. 2001;12(7):395–405.PubMedCrossRef Dabadie M, Valli N, Jacobin MJ, Laroche-Traineau J, Barat JL, Ducassou D, Nurden AT, Clofent-Sanchez G. Characterisation, cloning and sequencing of a conformation-dependent monoclonal antibody to the alphaIIbbeta3 integrin: interest for use in thrombus detection. Platelets. 2001;12(7):395–405.PubMedCrossRef
Metadata
Title
Ethylenediaminetetraacetate-dependent pseudothrombocytopenia accompanied by morphological changes
Authors
Weiyi Xu
Baode Chen
Yu Chen
Publication date
01-04-2014
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 4/2014
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-014-1558-2

Other articles of this Issue 4/2014

International Journal of Hematology 4/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine